Archive | About Tron

Aims and Expertise

TRON is a non-profit spin-off from the University Medicine Mainz and to this day its labs and offices remain close to the University campus. Our aim is to translate scientific findings into the clinic in collaboration with industry partners. To achieve this, we are active in basic, application-driven research in the fields of oncology and

Translation

Great ideas are the starting point, not the endpoint. We define ourselves through the act of putting inspiration into practice, finding viable solutions for challenges. Our mission is to translate scientific insight into clinical practice, developing innovative products for patients with high medical need. Historically, the pharmaceutical industry carried discoveries from basic research into clinical

Scientific Advisory Board

Five international experts from the fields of immunology and drug development advise TRON on pursuing new diagnostics and drugs for the treatment of cancer and other diseases of the immune system. TRON Scientific Advisory Board: Cornelis Melief Cornelis Melief (Chairman of the SAB) is Professor Emeritus of Immunohematology at the Leiden University Medical Centre in

Supervisory Board

Dr. Carola Zimmermann (chairperson) Ministry of Science, Education and Culture of the state Rhineland-Palatinate Dr. Waltraud Kreutz-Gers (deputy chairperson) Chancellor of the Johannes Gutenberg-University Mainz Ministerialrat Reinhold Bott Ministry of Fincance of the state Rhineland-Palatinate Prof. Dr. Dr. h.c. mult. Ernst Theodor Rietschel Professor Emeritus, former director of the Leibniz Association, former Chairman of the Berlin Institute of

Management

MANAGEMENT   Michael H. Föhlings … is Managing Director of TRON.   During his 30 years career in auditing, glass, steel and polymer industries, Michael has held diverse senior financial and general management functions in British, Anglo-Dutch and Swiss multinational companies. Concomitantly he was also a member of company boards in Germany, Italy, Spain, the

Faculty and Culture

TRON was founded on the idea that innovation transfer requires a facilitative environment, in which creative and passionate people from diverse backgrounds and complementary skills work together as teams to provide straightforward solutions to complex challenges. TRON is set up as a think tank, combining the strengths of hypothesis driven academic research and quality controlled

Background and History

Challenges in Translational Medicine Translating scientific concepts into clinical applications is a major contemporary challenge in medical health care. Expiring patents, empty pipelines of pharmaceutical companies and the increasing complexity of product development in the era of individualized medicine mean that even large pharmaceutical companies cannot address these challenges alone. At the same time, increasing

About TRON

TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz is a biopharmaceutical research organization that pursues new diagnostics and drugs for the treatment of cancer and other severe diseases with high medical need. A focus of TRON is the development of novel platforms for individualized therapies and biomarkers, translating